Valkit.ai
Valkit.ai provides a cloud-native, AI-augmented digital validation SaaS platform for pharmaceutical, biotechnology, and medical device companies, automating GxP-compliant lifecycle workflows from requirements through regulatory sign-off.
- Company typePrivate
- Founded2024
- HeadquartersIndianapolis, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Valkit.ai does
Valkit.ai is a cloud-native SaaS provider of digital validation software for the life sciences industry, serving pharmaceutical, biotechnology, and medical device organizations alongside CDMOs and greenfield facility projects. The company's flagship platform, SAFE GxP DVT, is a Gen 2 digital validation tool built on the S.A.F.E. framework (Safe, Agnostic, Fast, End-to-End) that combines human-in-the-loop AI, an LLM-agnostic architecture, rapid content authoring, and continuous lifecycle traceability from requirements through regulatory sign-off. Supporting modules include Valkit MSAT (GxP tech transfer for MSAT-led CDMO engagements), Valkit GREENFIELD (digital C&Q for new site start-ups), and operational modules for documents, traceability, real-time project dashboards, AI-augmented assurance, and enterprise security. A pre-validated R1125 'Odin' package is delivered with every release to compress customer qualification cycles.
The platform is monetized primarily through SaaS subscriptions on a project-license basis with multi-year contracts, featuring no named-seat fees, unlimited collaborators, and optional managed services delivered through certified channel partners across the US, UK, EU, India, and APAC. Distribution combines direct enterprise field sales with a partner network — most notably an August 2025 strategic partnership with Life Science Consulting (Conval Group) covering India operations and extending into Asia and Europe. Infrastructure spans 19 Amazon regions with 10-language support. Compliance posture is layered, including ISO 27001:2022, CSA STAR Level One and CSA STAR for AI Level One, EU/UK/Swiss Data Privacy Framework certifications, GDPR/CCPA alignment, and 21 CFR Part 11 / EU GMP Annex 11 readiness for electronic records and signatures.
Valkit.ai firmographics
Firmographics- Name
- Valkit.ai
- Legal name
- Valkit.ai LLC
- Website
- https://valkit.ai
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Valkit.ai provides a cloud-native, AI-augmented digital validation SaaS platform for pharmaceutical, biotechnology, and medical device companies, automating GxP-compliant lifecycle workflows from requirements through regulatory sign-off.
- Ownership category
- akta.pro rank
Valkit.ai industry classification
Industry- Product category
- GxP Digital Validation Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs) (HLAGAJAI)
- akta.pro secondary industry
- Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies) (HDAEANAE)
Keywords
Where Valkit.ai is headquartered
LocationHeadquarters
- HQ city
- Indianapolis
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Valkit.ai business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations, Others
Revenue model
- SaaS Platform Subscription (Project License): Cloud-native SaaS subscription model structured around project licenses. Each project license covers a full validation engagement — from kick-off to sign-off — with no per-seat fees, no overage charges, and predictable spend. No named seat fees; unlimited collaborators included at no additional cost.
- Optional Managed Services: Recurring fee for fully managed delivery via approved Valkit delivery partners. Based on partner geography, capability level, and engagement utilization. Covers end-to-end C&Q engagement managed entirely within the Valkit platform.
- One-Time Implementation Fee: One-time implementation fee paid at project kick-off, covering onboarding, platform configuration, template cloning, user provisioning, and team training. No implementation fee mentioned in some contexts (frictionless cloud-based approach).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Valkit MSAT - GxP tech transfer for MSAT-led CDMO engagements |
| Subscription | Multi-year contract | Valkit GREENFIELD - Digital C&Q for new site start-up |
| Subscription | Annual | Flexible pricing plans tailored to organization needs. Contact sales team at [email protected] for details. |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Valkit.ai product offering
Product offeringCore offering
Valkit.ai sells a cloud-native Gen 2 SaaS digital validation platform — anchored by its flagship SAFE GxP DVT product built on the proprietary S.A.F.E. framework (Safe, Agnostic, Fast, End-to-End) — that automates the GxP validation lifecycle for pharmaceutical, biotech, and medical device organizations. The platform covers requirements authoring, risk assessment, paperless test execution (IQ/OQ/PQ), automated traceability matrices, deviation management, and 21 CFR Part 11 / EU Annex 11 e-signatures, augmented by an LLM-agnostic agentic AI layer with mandatory human-in-the-loop review.
Product overview
Valkit.ai is a comprehensive Gen 2 digital validation platform for the life sciences industry, combining a modular architecture of specialized modules with AI-powered automation. The core platform is anchored by SAFE GxP DVT, the company's flagship AI-powered digital validation tool built on the S.A.F.E. framework. Supporting modules include Valkit MSAT (for GxP tech transfer and MSAT-led CDMO engagements), Valkit GREENFIELD (for digital C&Q at new site start-ups), and core operational modules for Project Management & Cloning, Documents, Traceability, Real-Time Dashboards, AI-Augmented Assurance, and Security. All modules share the same platform infrastructure, with a pre-validated R1125 'Odin' platform delivering validation packages (VP, PRD, FRA, OQ, TMX, VSR) with every release. The platform integrates natively with Jira and Azure DevOps and supports custom LLM APIs.
Differentiator
Problem solved
Functional benefit
Brands
- SAFE GxP DVT: S.A.F.E. framework: human-in-the-loop AI for GxP digital validation - a proprietary framework combining Safe, Agnostic, Fast, and End-to-End principles for regulated digital validation.
- Valkit MSAT
- Valkit GREENFIELD
Products and services
- SAFE GxP DVT The flagship AI-powered digital validation product built on the S.A.F.E. framework. SAFE stands for Safe (human-in-the-loop AI where every AI output requires mandatory human review and e-signature before entering the record), Agnostic (open LLM architecture not locked to any single AI provider), Fast (rapid authoring from system descriptions, uploaded docs, or unstructured legacy sources), and End-to-End (single continuous lifecycle from requirements through risk assessment, test execution, and sign-off). It targets pharmaceutical, biotech, and medical device organizations running CQV, CSV, CSA, instrument validation, lab validation, and cleaning validation under GxP regulations.
- Valkit MSAT A GxP tech transfer platform purpose-built for MSAT-led CDMO engagements. It enables disciplined and repeatable tech transfer projects between pharmaceutical sponsors and CDMOs within one isolated project environment, providing clear ownership, full transparency, and fixed project licensing. Sold as a separate product on a multi-year project-license subscription basis with every feature included and no named seats.
- Valkit GREENFIELD A digital C&Q platform for new pharmaceutical, biotech, and medical device site start-ups. Provides paperless IQ/OQ/PQ protocol execution, AI-augmented authoring, and zero-GDP-error execution, designed to take a facility from ground-break to qualified status. Sold as a separate product on a multi-year project-license subscription basis with unlimited collaborators and an optional managed service fee via approved delivery partners.
Quantifiable outcome
- 80% reduction in lifecycle validation costs through smart automations, packages cloning, master data management, and AI augmentation
- +7 more outcomes
Companies that use Valkit.ai
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
Valkit.ai technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability7 records
Feature8 records
Valkit.ai partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Life Science Consulting Pvt Limited (Conval Group Company)coreLife Science Consulting Pvt Limited, a Conval Group Company and 25-year validation services leader, became Valkit.ai's country partner for India operations. This strategic partnership expands access to Valkit.ai's AI-powered digital validation platform across Asia and Europe. The partnership combines Valkit.ai's cloud-native platform (delivering 80% reduction in lifecycle validation costs and 50% faster execution) with Conval's extensive expertise serving over 200 pharmaceutical clients including Novartis, Pfizer, and Roche. The collaboration targets the global testing and commissioning market valued at $254 billion in 2024, projected to reach $366.9 billion by 2033.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Valkit.ai competitors and assessment
Company assessmentDirect peers
- ValGenesis: Direct competitor offering a digital validation platform (ValGenesis VLMS) for life sciences covering CQV, CSV, and process validation. Targets the same pharmaceutical, biotech, and medical device buyers with a comparable SaaS value proposition and is widely considered the category leader Valkit must displace.
- Kneat Solutions: Kneat Gx is a cloud-based computerized system validation (CSV) and commissioning/qualification platform used by top-tier pharma and medical device manufacturers. It competes head-to-head with Valkit across C&Q, CSV, and lab validation use cases.
- AssurX: AssurX delivers configurable quality management and compliance workflow software for regulated industries including life sciences. Its validation and document control capabilities compete with parts of Valkit's Trace and Documents modules for the same GxP customer base.
Emerging players
- Qualio: Qualio provides a cloud QMS for life sciences startups and mid-market companies, including document control and validation support. It addresses a similar GxP compliance pain point as Valkit but with a broader QMS frame and a focus on smaller pre-IPO life sciences organizations.
- Dot Compliance: Dot Compliance offers a Salesforce-native eQMS/QMS platform for life sciences covering deviations, CAPA, audits, and change control. It overlaps with Valkit's compliance-adjacent use cases and targets similar mid-market and enterprise pharma/biotech buyers with a modern cloud-native posture.
- Greenlight Guru: Greenlight Guru is a QMS and quality management platform purpose-built for medical device companies, overlapping with Valkit's medical device validation segment. It is a relevant adjacent peer for the MD&D portion of Valkit's customer base.
Broad incumbents
- LabWare: LabWare is a leading LIMS/ELN vendor used by pharma, biotech, and contract labs. It is a broad incumbent in adjacent laboratory informatics and shares overlap with Valkit's lab validation use cases, though LabWare's center of gravity is the lab itself rather than the validation lifecycle.
- MasterControl: MasterControl provides a broad life sciences QMS/eQMS platform that includes document control, training, and validation tooling. It is an incumbent at many of the same regulated customers Valkit targets but with a much wider product footprint rather than a validation-specialist focus.
- Veeva Systems: Veeva is the dominant enterprise SaaS platform for life sciences across CRM, regulatory, quality, and clinical. Its Vault Quality and Validation offerings overlap with parts of Valkit's surface area and define the procurement-default incumbent for many large pharma accounts.
- Sparta Systems (Honeywell TrackWise): TrackWise (now part of Honeywell) is an enterprise quality management platform widely deployed in life sciences for deviations, CAPA, change control, and validation workflows. It is a broad incumbent with overlapping validation-related capabilities serving many of the same large pharma customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Customer concentration
Valkit.ai social profiles
Digital presenceValkit.ai compliance and trust
Trust signalCompliance9 records
Valkit.ai financial estimates
Financial estimateRevenue estimate
Valuation estimate
Valkit.ai leadership team
Management profileNumber of profiles
Profiles4 records
Valkit.ai funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Valkit.ai M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Valkit.ai
What does Valkit.ai do?
Valkit.ai sells a cloud-native Gen 2 SaaS digital validation platform — anchored by its flagship SAFE GxP DVT product built on the proprietary S.A.F.E. framework (Safe, Agnostic, Fast, End-to-End) — that automates the GxP validation lifecycle for pharmaceutical, biotech, and medical device organizations. The platform covers requirements authoring, risk assessment, paperless test execution (IQ/OQ/PQ), automated traceability matrices, deviation management, and 21 CFR Part 11 / EU Annex 11 e-signatures, augmented by an LLM-agnostic agentic AI layer with mandatory human-in-the-loop review.
Is Valkit.ai a public or private company?
Valkit.ai is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Valkit.ai founded?
Valkit.ai was founded in 2024. It employs 11 to 50 people.
Where is Valkit.ai based?
Valkit.ai is headquartered in Indianapolis, United States, in the North America region.
How does Valkit.ai make money?
Three revenue lines are on record. SaaS Platform Subscription (Project License) is the primary driver. The others are optional Managed Services and one-Time Implementation Fee.
Who are Valkit.ai's main competitors?
Direct peers on record are ValGenesis, Kneat Solutions and AssurX. Emerging players are Qualio, Dot Compliance and Greenlight Guru. Broad incumbents are LabWare, MasterControl, Veeva Systems and Sparta Systems (Honeywell TrackWise).
Does Valkit.ai have an API?
No public API is recorded for Valkit.ai.
What industry is Valkit.ai in?
Valkit.ai's product category is GxP Digital Validation Software. Its primary akta.pro industry code is HLAGAJAI, Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs), with a secondary code of HDAEANAE, Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies). Its NAICS code is 5132 and its SIC code is 7372.